Premium
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively... Verve Therapeutics Inc is a genetic medicines company pioneering a new approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. The company's initial two programs target PCSK9 and ANGPTL3, genes that have been extensively validated as targets for lowering blood lipids such as low-density lipoprotein cholesterol, a root cause of cardiovascular disease. The company views its operations as and manages its business in one operating segment operating exclusively in the United States. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.54 | 9.21501706485 | 5.86 | 6.81 | 5.64 | 1609363 | 6.37468041 | CS |
| 4 | -1.5 | -18.9873417722 | 7.9 | 9.305 | 5.64 | 1375960 | 6.93315816 | CS |
| 12 | 1.02 | 18.9591078067 | 5.38 | 9.305 | 4.88 | 1514192 | 6.7418909 | CS |
| 26 | 0.79 | 14.0819964349 | 5.61 | 9.305 | 4.37 | 1458684 | 6.14379975 | CS |
| 52 | -8.59 | -57.3048699133 | 14.99 | 15.55 | 4.305 | 1433035 | 6.48416595 | CS |
| 156 | -22.4 | -77.7777777778 | 28.8 | 43 | 4.305 | 1119426 | 13.80749279 | CS |
| 260 | -23.6 | -78.6666666667 | 30 | 78 | 4.305 | 996129 | 16.61616293 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
